ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade

por Liu, Xiaolan, Cen, Xufeng, Wu, Ronghai, Chen, Ziyan, Xie, Yanqi, Wang, Fengqi, Shan, Bing, Zeng, Linghui, Zhou, Jichun, Xie, Bojian, Cai, Yangjun, Huang, Jinyan, Liang, Yingjiqiong, Wu, Youqian, Zhang, Chao, Wang, Dongrui, Xia, Hongguang
Publicado 2023

Treatment of allergic eosinophilic asthma through engineered IL-5-anchored chimeric antigen receptor T cells

por Chen, Sisi, Chen, Gaoying, Xu, Fang, Sun, Beibei, Chen, Xinyi, Hu, Wei, Li, Fei, Syeda, Madiha Zahra, Chen, Haixia, Wu, Youqian, Wu, Peng, Jing, Ruirui, Geng, Xinwei, Zhang, Lingling, Tang, Longguang, Li, Wen, Chen, Zhihua, Zhang, Chao, Sun, Jie, Chen, Wei, Shen, Huahao, Ying, Songmin
Publicado 2022

ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation

por Wu, Youqian, Zhang, Chao, Liu, Xiaolan, He, Zhengfu, Shan, Bing, Zeng, Qingxin, Zhao, Qingwei, Zhu, Huaying, Liao, Hongwei, Cen, Xufeng, Xu, Xiaoyan, Zhang, Mengmeng, Hou, Tingjun, Wang, Zhe, Yan, Huanhuan, Yang, Shuying, Sun, Yaqin, Chen, Yanying, Wu, Ronghai, Xie, Tingxue, Chen, Wei, Najafov, Ayaz, Ying, Songmin, Xia, Hongguang
Publicado 2021